Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder

Central GLP-1 receptors: Novel molecular targets for cocaine use disorder

(2019) N.S. Hernandez et al.   PHYSIOLOGY & BEHAVIOR

Glucagon-like peptide 1 (GLP-1)

(2019) T.D. Müller et al.   Molecular Metabolism

Exenatide once weekly for smoking cessation

(2018) Luba Yammine et al.   MEDICINE

Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats

(2018) Nicole S. Hernandez et al.   NEUROPSYCHOPHARMACOLOGY

Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial

(2018) Kerstin K Antonsen et al.   BMJ Open

Cocaine and cocaine expectancy increase growth hormone, ghrelin, GLP-1, IGF-1, adiponectin, and corticosterone while decreasing leptin, insulin, GIP, and prolactin

(2018) Zhi-Bing You et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Review of head-to-head comparisons of glucagon-like peptide-1 receptor agonists

(2015) Sten Madsbad   DIABETES OBESITY & METABOLISM

Peripheral Mechanisms in Appetite Regulation

(2015) Michael Camilleri   GASTROENTEROLOGY

Glucagon-Like Peptide-1 Receptor Activation in the Ventral Tegmental Area Decreases the Reinforcing Efficacy of Cocaine

(2015) Heath D Schmidt et al.   NEUROPSYCHOPHARMACOLOGY

Septal Glucagon-Like Peptide 1 Receptor Expression Determines Suppression of Cocaine-Induced Behavior

(2015) Anne E Harasta et al.   NEUROPSYCHOPHARMACOLOGY

The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice

(2015) Gunnar Sørensen et al.   PHYSIOLOGY & BEHAVIOR

Incretins and Amylin: Neuroendocrine Communication Between the Gut, Pancreas, and Brain in Control of Food Intake and Blood Glucose

(2014) Matthew R. Hayes et al.   Annual Review of Nutrition

GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in Humans

(2014) L. van Bloemendaal et al.   DIABETES

Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight

(2014) Laurie L. Baggio et al.   JOURNAL OF CLINICAL INVESTIGATION

The skinny on cocaine: Insights into eating behavior and body weight in cocaine-dependent men

(2013) Karen D. Ersche et al.   APPETITE

The Addictive Dimensionality of Obesity

(2013) Nora D. Volkow et al.   BIOLOGICAL PSYCHIATRY

The Glucagon-Like Peptide 1 Analogue, Exendin-4, Attenuates the Rewarding Properties of Psychostimulant Drugs in Mice

(2013) Emil Egecioglu et al.   PLoS One

The Effect of Glucagon-Like Peptide-1 Receptor Agonist Therapy on Body Mass Index in Adolescents With Severe Obesity

(2013) Aaron S. Kelly et al.   JAMA Pediatrics

Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers

(2012) Rebecca L Ashare et al.   JOURNAL OF PSYCHOPHARMACOLOGY

GLP-1 analog attenuates cocaine reward

(2012) D L Graham et al.   MOLECULAR PSYCHIATRY

A single-day paradigm of self-regulated human cocaine administration

(2012) D. Matuskey et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Exendin-4 decreases amphetamine-induced locomotor activity

(2012) Kevin Erreger et al.   PHYSIOLOGY & BEHAVIOR

Novel pharmacotherapeutic treatments for cocaine addiction

(2011) Daryl Shorter et al.   BMC Medicine

Short-Term Exenatide Treatment Leads to Significant Weight Loss in a Subset of Obese Women Without Diabetes

(2011) J. Dushay et al.   DIABETES CARE

The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide

(2011) Scott E. Kanoski et al.   NEUROPHARMACOLOGY

Efficacy of Varenicline to Prompt Quit Attempts in Smokers Not Currently Trying to Quit: A Randomized Placebo-Controlled Trial

(2011) J. R. Hughes et al.   NICOTINE & TOBACCO RESEARCH

The role of gut hormones and the hypothalamus in appetite regulation

(2010) Keisuke Suzuki et al.   ENDOCRINE JOURNAL

Exenatide: A new promising antidiabetic agent

(2010) CK Chakraborti   INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES

Regulation of cocaine self-administration in humans: Lack of evidence for loading and maintenance phases

(2009) Gustavo A. Angarita et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Cocaine decreases plasma insulin concentrations in non-diabetic subjects: a randomized double-blind study

(2008) D. Rott et al.   DIABETIC MEDICINE

Common predictors of smoking cessation in clinical practice

(2008) Pasquale Caponnetto et al.   RESPIRATORY MEDICINE